Proteasome activity restricts lentiviral gene transfer into hematopoietic stem cells and is down-regulated by cytokines that enhance transduction.

Abstract:

:The therapeutic potential of hematopoietic stem cell (HSC) gene therapy can be fully exploited only by reaching efficient gene transfer into HSCs without compromising their biologic properties. Although HSCs can be transduced by HIV-derived lentiviral vectors (LVs) in short ex vivo culture, they display low permissivity to the vector, requiring cytokine stimulation to reach high-frequency transduction. Using stringent assays of competitive xenograft repopulation, we show that early-acting cytokines synergistically enhanced human HSC gene transfer by LVs without impairing engraftment and repopulation capacity. Using S-phase suicide assays, we show that transduction enhancement by cytokines was not dependent on cell cycle progression and that LVs can transduce quiescent HSCs. Pharmacologic inhibition of the proteasome during transduction dramatically enhanced HSC gene transfer, allowing the reach of very high levels of vector integration in their progeny in vivo. Thus, LVs are effectively restricted at a postentry step by the activity of this proteolytic complex. Unexpectedly, cytokine stimulation rapidly and substantially down-regulated proteasome activity in hematopoietic progenitors, highlighting one mechanism by which cytokines may enhance permissiveness to LV gene transfer. These findings demonstrate that antiviral responses ultimately mediated by proteasomes strongly limit the efficiency of HSC transduction by LVs and establish improved conditions for HSC-based gene therapy.

journal_name

Blood

journal_title

Blood

authors

Santoni de Sio FR,Cascio P,Zingale A,Gasparini M,Naldini L

doi

10.1182/blood-2005-10-4047

subject

Has Abstract

pub_date

2006-06-01 00:00:00

pages

4257-65

issue

11

eissn

0006-4971

issn

1528-0020

pii

2005-10-4047

journal_volume

107

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Bispecific antibody-mediated immunotherapy of the BCL1 lymphoma: increased efficacy with multiple injections and CD28-induced costimulation.

    abstract::The BCL1 lymphoma in Balb/c mice can be successfully treated with bispecific (anti-CD3 x anti-idiotype) antibodies (BSABs). In these experiments, animals were injected intraperitoneally (IP) with 5 x 10(3) tumor cells (day 0) and treated with one single intravenous (IV) injection of 5 micrograms BSAB (day 9). Because ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Demanet C,Brissinck J,De Jonge J,Thielemans K

    更新日期:1996-05-15 00:00:00

  • Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease.

    abstract::Graft-versus-host disease (GVHD) is the main complication of allogeneic stem cell transplantation. However, diagnosis of GVHD and evaluation of response to immunosuppressive treatment is sometimes difficult. Since apoptosis is the histopathologic hallmark in GVHD, we investigated whether active GVHD-induced target org...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-10-049817

    authors: Luft T,Conzelmann M,Benner A,Rieger M,Hess M,Strohhaecker U,Görner M,Hegenbart U,Ho AD,Dreger P

    更新日期:2007-12-15 00:00:00

  • High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease.

    abstract::Between February 1986 and March 1990, 56 patients with relapsed Hodgkin's disease treated with high-dose cyclophosphamide, carmustine, and etoposide (CBV) received an autologous peripheral stem cell transplantation (PSCT) rather than an autologous bone marrow transplantation (ABMT) because each patient had a marrow ab...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kessinger A,Bierman PJ,Vose JM,Armitage JO

    更新日期:1991-06-01 00:00:00

  • Platelet-associated complement C3 in immune thrombocytopenic purpura.

    abstract::Platelet-associated C3 (PA-C3) was measured with a quantitative immunofluorescence assay. With this assay, PA-C3 levels were determined for 78 normal volunteers, 30 patients with immune thrombocytopenic purpura (ITP), and 20 patients with nonimmune thrombocytopenias. Platelet-associated IgG (PA-IgG) levels were also m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Myers TJ,Kim BK,Steiner M,Baldini MG

    更新日期:1982-05-01 00:00:00

  • High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy.

    abstract::Seventy-five patients with resistant acute leukemia or lymphoma received high-dose cyclophosphamide and etoposide to explore the activity of this combination in resistant hematologic malignancies, and to determine the maximum doses of these drugs that can be combined without bone marrow transplantation. Etoposide was ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Brown RA,Herzig RH,Wolff SN,Frei-Lahr D,Pineiro L,Bolwell BJ,Lowder JN,Harden EA,Hande KR,Herzig GP

    更新日期:1990-08-01 00:00:00

  • Role of light chain variable region in myeloma with light chain deposition disease: evidence from an experimental model.

    abstract::Light chain deposition disease (LCDD) results from a propensity of some human monoclonal L chains to form tissue deposits. We designed an experimental model for in vivo expression of human kappa L chain sequences in mice and compared a somatically mutated LCDD chain with a closely related control kappa chain, both enc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Khamlichi AA,Rocca A,Touchard G,Aucouturier P,Preud'homme JL,Cogné M

    更新日期:1995-11-15 00:00:00

  • Alloimmunization following prophylactic granulocyte transfusion.

    abstract::Nineteen noninfected adults receiving initial induction chemotherapy for acute nonlymphocytic leukemia (ANLL) were randomized to receive either prophylactic granulocyte transfusion or platelet transfusion alone on an alternate-day schedule. An average of 11 granulocyte transfusions (range 3--19) were administered/pati...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Schiffer CA,Aisner J,Daly PA,Schimpff SC,Wiernik PH

    更新日期:1979-10-01 00:00:00

  • Prophylactic transfer of BCR-ABL-, PR1-, and WT1-reactive donor T cells after T cell-depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemia.

    abstract::Donor lymphocyte infusions have been effective in patients with chronic myeloid leukemia (CML) relapsing after allogeneic stem cell transplantation, but their use is associated with the risk of graft-versus-host disease. We investigated the effects of prophylactic infusion of in vitro-generated donor T cells reactive ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-09-308569

    authors: Bornhäuser M,Thiede C,Platzbecker U,Kiani A,Oelschlaegel U,Babatz J,Lehmann D,Hölig K,Radke J,Tuve S,Wermke M,Wehner R,Jähnisch H,Bachmann MP,Rieber EP,Schetelig J,Ehninger G,Schmitz M

    更新日期:2011-06-30 00:00:00

  • Mutations of the PML tumor suppressor gene in acute promyelocytic leukemia.

    abstract::The promyelocytic leukemia (PML) tumor suppressor of acute promyelocytic leukemia (APL) is essential for a number of proapoptotic and growth-suppressive pathways as well as for the activity of differentiating agents such as retinoic acid (RA). In human APL, the dose of PML is reduced to heterozygosity given that one a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-07-2200

    authors: Gurrieri C,Nafa K,Merghoub T,Bernardi R,Capodieci P,Biondi A,Nimer S,Douer D,Cordon-Cardo C,Gallagher R,Pandolfi PP

    更新日期:2004-03-15 00:00:00

  • V(D)J recombinatorial repertoire diversification during intraclonal pro-B to B-cell differentiation.

    abstract::The initial B-cell repertoire is generated by combinatorial immunoglobulin V(D)J gene segment rearrangements that occur in a preferential sequence. Because cellular proliferation occurs during the course of these rearrangement events, it has been proposed that intraclonal diversification occurs during this phase of B-...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-06-1828

    authors: Wang YH,Zhang Z,Burrows PD,Kubagawa H,Bridges SL Jr,Findley HW,Cooper MD

    更新日期:2003-02-01 00:00:00

  • Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease.

    abstract::The incidence and severity of acute graft-versus-host disease (GVHD) after allogeneic transplantation using peripheral blood progenitor cells mobilized by granulocyte colony-stimulating factor (G-CSF) appear to be no worse than those after bone marrow transplantation, despite the presence of large numbers of T cells i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pan L,Delmonte J Jr,Jalonen CK,Ferrara JL

    更新日期:1995-12-15 00:00:00

  • Chemotherapy-only treatment effects on long-term neurocognitive functioning in childhood ALL survivors: a review and meta-analysis.

    abstract::Therapy for childhood acute lymphoblastic leukemia (ALL) is associated with 5-year survival rates of ∼90% even after largely eliminating cranial radiation. This meta-analysis assesses the long-term neurocognitive functioning after chemotherapy-only regimens among survivors of childhood ALL. We conducted a systematic r...

    journal_title:Blood

    pub_type: 杂志文章,meta分析,评审

    doi:10.1182/blood-2015-02-627414

    authors: Iyer NS,Balsamo LM,Bracken MB,Kadan-Lottick NS

    更新日期:2015-07-16 00:00:00

  • How I treat acute myeloid leukemia in the era of new drugs.

    abstract::The acute myeloid leukemia (AML) treatment landscape has changed substantially since 2017. New targeted drugs have emerged, including venetoclax to target B-cell lymphoma 2, midostaurin and gilteritinib to target FLT3, and ivosidenib and enasidenib to target mutant isocitrate dehydrogenase 1 and 2, respectively. Other...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019001239

    authors: DiNardo CD,Wei AH

    更新日期:2020-01-09 00:00:00

  • Atypical presentation of Wiskott-Aldrich syndrome: diagnosis in two unrelated males based on studies of maternal T cell X chromosome inactivation.

    abstract::Congenital thrombocytopenia may occur in isolation or accompanied by eczema and immunodeficiency, as part of the X-linked hereditary Wiskott-Aldrich syndrome (WAS). Because the clinical and immunologic picture of WAS is variable, particularly early in life, definite diagnosis cannot always be made in cases with a nega...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Puck JM,Siminovitch KA,Poncz M,Greenberg CR,Rottem M,Conley ME

    更新日期:1990-06-15 00:00:00

  • Single-copy transduction and expression of human gamma-globin in K562 erythroleukemia cells using recombinant adeno-associated virus vectors: the effect of mutations in NF-E2 and GATA-1 binding motifs within the hypersensitivity site 2 enhancer.

    abstract::The use of recombinant adeno-associated virus (rAAV) vectors provides a new strategy to investigate the role of specific regulatory elements and trans-acting factors in globin gene expression. We linked hypersensitivity site 2 (HS2) from the locus control region (LCR) to a A gamma-globin gene (A gamma*) mutationally m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Miller JL,Walsh CE,Ney PA,Samulski RJ,Nienhuis AW

    更新日期:1993-09-15 00:00:00

  • Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target.

    abstract::Acute myeloid leukemia (AML) is one of the most common acute leukemias in adults and children, yet significant numbers of patients relapse and die of disease. In this study, we identify the dependence of AML blasts on arginine for proliferation. We show that AML blasts constitutively express the arginine transporters ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-09-600643

    authors: Mussai F,Egan S,Higginbotham-Jones J,Perry T,Beggs A,Odintsova E,Loke J,Pratt G,U KP,Lo A,Ng M,Kearns P,Cheng P,De Santo C

    更新日期:2015-04-09 00:00:00

  • High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia.

    abstract::By using an enzyme-linked immunosorbent assay, the presence of the soluble form of the interleukin-2 receptor (sIL-2R) was evaluated in the peripheral blood of 54 patients with B cell chronic lymphocytic leukemia (B-CLL). Serum levels of sIL-2R were correlated with clinical features, relevant hematologic and immunolog...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Semenzato G,Foa R,Agostini C,Zambello R,Trentin L,Vinante F,Benedetti F,Chilosi M,Pizzolo G

    更新日期:1987-08-01 00:00:00

  • Specific inhibition of HIV-1 coreceptor activity by synthetic peptides corresponding to the predicted extracellular loops of CCR5.

    abstract::We used synthetic peptides to the extracellular loops (ECLs) of CCR5 to examine inhibitory effects on HIV infection/fusion with primary leukocytes and cells expressing recombinant CCR5. We show for the first time that peptides derived from the first, second, or third ECL caused dose-dependent inhibition of fusion and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-08-2669

    authors: Agrawal L,VanHorn-Ali Z,Berger EA,Alkhatib G

    更新日期:2004-02-15 00:00:00

  • In vivo inhibition by a site-specific catalytic RNA subunit of RNase P designed against the BCR-ABL oncogenic products: a novel approach for cancer treatment.

    abstract::One major obstacle to the effective treatment of cancer is to distinguish between tumor cells and normal cells. The chimeric molecules created by cancer-associated chromosomal abnormalities are ideal therapeutic targets because they are unique to the disease. We describe the use of a novel approach based on the cataly...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cobaleda C,Sánchez-García I

    更新日期:2000-02-01 00:00:00

  • Neutral tumor evolution in myeloma is associated with poor prognosis.

    abstract::Recent studies suggest that the evolutionary history of a cancer is important in forecasting clinical outlook. To gain insight into the clonal dynamics of multiple myeloma (MM) and its possible influence on patient outcomes, we analyzed whole exome sequencing tumor data for 333 patients from Myeloma XI, a UK phase 3 t...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2016-11-750612

    authors: Johnson DC,Lenive O,Mitchell J,Jackson G,Owen R,Drayson M,Cook G,Jones JR,Pawlyn C,Davies FE,Walker BA,Wardell C,Gregory WM,Cairns D,Morgan GJ,Houlston RS,Kaiser MF

    更新日期:2017-10-05 00:00:00

  • Pericapillary hemorrhage as criterion of severe human digestive graft-versus-host disease.

    abstract::In an experimental model we demonstrated that endothelial cells of all organs are targets of the alloimmune reaction. Here, in 68 digestive biopsies, we found endothelial lesions by immunohistochemistry and ultrastructure in patients with severe acute graft-versus-host disease (GVHD). In contrast, no such endothelial ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-05-1548

    authors: Ertault-Daneshpouy M,Leboeuf C,Lemann M,Bouhidel F,Ades L,Gluckman E,Socié G,Janin A

    更新日期:2004-06-15 00:00:00

  • Active amino acids of the Kell blood group protein and model of the ectodomain based on the structure of neutral endopeptidase 24.11.

    abstract::In addition to its importance in transfusion, Kell protein is a member of the M13 family of zinc endopeptidases and functions as an endothelin-3-converting enzyme. To obtain information on the structure of Kell protein we built a model based on the crystal structure of the ectodomain of neutral endopeptidase 24.11 (NE...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-05-1564

    authors: Lee S,Debnath AK,Redman CM

    更新日期:2003-10-15 00:00:00

  • Characterization of the mouse von Willebrand factor promoter.

    abstract::Expression of the von Willebrand factor (vWF) gene is restricted to the endothelial and megakaryocyte lineages. Within the endothelium, expression of vWF varies between different vascular beds. We have previously shown that the human vWF promoter spanning a region between -2182 (relative to the start site of transcrip...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Guan J,Guillot PV,Aird WC

    更新日期:1999-11-15 00:00:00

  • The effect of alpha-thalassemia on the expression of the beta-thalassemia/HPFH heterozygote in a black family.

    abstract::A 2-yr-old black girl presented with a thalassemic clinical picture and was found to have nearly 100% fetal hemoglobin in her red cells. Pedigree analysis indicated that she was a heterozygote for the hereditary persistence of fetal hemoglobin gene and for a beta O-thalassemia gene. A brother, who also had nearly 100%...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Beutler E,Turner E,Kuhl W

    更新日期:1981-06-01 00:00:00

  • Lymphoid precursors are directed to produce dendritic cells as a result of TLR9 ligation during herpes infection.

    abstract::Hematopoietic stem and progenitor cells were previously found to express Toll-like receptors (TLRs), suggesting that bacterial/viral products may influence blood cell formation. We now show that common lymphoid progenitors (CLPs) from mice with active HSV-1 infection are biased to dendritic cell (DC) differentiation, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-04-151506

    authors: Welner RS,Pelayo R,Nagai Y,Garrett KP,Wuest TR,Carr DJ,Borghesi LA,Farrar MA,Kincade PW

    更新日期:2008-11-01 00:00:00

  • Second to none.

    abstract::In this issue of Blood, Usmani et al provide important information on second primary malignancies in patients treated with thalidomide and lenalidomide in the Arkansas total therapy trials. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2012-07-439158

    authors: Rajkumar SV

    更新日期:2012-08-23 00:00:00

  • Expression of p13MTCP1 is restricted to mature T-cell proliferations with t(X;14) translocations.

    abstract::T-cell prolymphocytic leukemia (T-PLL), a rare form of mature T-cell leukemias, and ataxia telangiectasia clonal proliferation, a related condition occurring in patients suffering from ataxia telangiectasia, have been associated to translocations involving the 14q32.1 or Xq28 regions, where are located the TCL1 and MT...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Madani A,Choukroun V,Soulier J,Cacheux V,Claisse JF,Valensi F,Daliphard S,Cazin B,Levy V,Leblond V,Daniel MT,Sigaux F,Stern MH

    更新日期:1996-03-01 00:00:00

  • Autoreactive MZ and B-1 B-cell activation by Faslpr is coincident with an increased frequency of apoptotic lymphocytes and a defect in macrophage clearance.

    abstract::Murine autoreactive anti-Smith (Sm) B cells are negatively regulated by anergy and developmental arrest, but are also positively selected into the marginal zone (MZ) and B-1 B-cell populations. Despite positive selection, anti-Sm production occurs only in autoimmune-prone mice. To investigate autoreactive B-cell activ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-12-006858

    authors: Qian Y,Conway KL,Lu X,Seitz HM,Matsushima GK,Clarke SH

    更新日期:2006-08-01 00:00:00

  • Adenovirus-mediated intralesional interferon-gamma gene transfer induces tumor regressions in cutaneous lymphomas.

    abstract::Primary cutaneous lymphomas have been successfully treated with interferons (IFNs), counterbalancing the T-helper 2 (Th2)-skewing state. We undertook a phase 1, open-label, dose-escalating trial of repeated intratumoral administration of TG1042 in patients with advanced primary cutaneous T-cell lymphomas (CTCLs) and m...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2004-01-0360

    authors: Dummer R,Hassel JC,Fellenberg F,Eichmüller S,Maier T,Slos P,Acres B,Bleuzen P,Bataille V,Squiban P,Burg G,Urosevic M

    更新日期:2004-09-15 00:00:00

  • The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria.

    abstract::Pattern recognition receptors (PRRs) play an essential role in a macrophage's response to mycobacterial infections. However, how these receptors work in concert to promote this macrophage response remains unclear. In this study, we used bone marrow-derived macrophages isolated from mannose receptor (MR), complement re...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-05-024406

    authors: Yadav M,Schorey JS

    更新日期:2006-11-01 00:00:00